12 research outputs found

    Anti-PD1 does not improve pyroptosis induced by Ī³Ī“ T cells but promotes tumor regression in a pleural mesothelioma mouse model

    Get PDF
    IntroductionMesothelioma is an aggressive tumor in the pleural cavity that is difficult to treat. Diagnosis is usually late with minimal treatment options available for the patients and with unfavorable outcomes. However, recent advances in immunotherapy using Ī³Ī“ T cells may have potential against mesothelioma, given its ample tumoricidal and tumor-migratory properties could allow its infiltration to the widespread tumor mass. Thus, we hypothesize that VĪ“2 T cells can perform cytotoxic activities against mesothelioma especially when combined with immune checkpoint blocker against PD-1.MethodsHuman VĪ“2 T cells were expanded from peripheral blood mononuclear cells using Tetrakisā€pivaloyloxymethyl 2ā€(thiazoleā€2ā€ylamino) ethylideneā€1,1ā€bisphosphonate (PTA) plus IL-2 for 13 days, before used to test for cytotoxicity against mesothelioma cell lines. Mesothelioma-bearing mice was established by Intrapleural administration of mesothelioma cell lines to test for the efficacy of VĪ“2 T cells plus anti-PD-1 antibody combination treatment. Pyroptosis was evaluated by cell morphology, western blot analysis, and ELISA experiments. Flow cytometry was used to examine expression of BTN2A1, BTN3A1, PD-L1, PD-L2 on mesothelioma cell lines. Immunofluorescence staining was performed to detect VĪ“2 T cells post adoptive transfer and characteristics of pyroptosis in ex vivo mesothelioma tissue sections.ResultsIndeed, our data demonstrated that VĪ“2 T cells killing mesothelioma can be enhanced by anti-PD-1 antibody in vitro, especially for high PD-1 expressing cells, and in vivo in the intrapleural mesothelioma mice model established by us. Adoptive transfer of VĪ“2 T cells into these mice leads to tumor regression by 30-40% compared to control. Immunofluorescence of the tumor section confirmed infiltration of VĪ“2 T cells into the tumor, especially to cells with BTN2A1 expression (a VĪ“2 T cell activating molecule) despite PD-L1 co-localization. Interestingly, these cells co-expressed cleaved gasdermin D, suggesting that pyroptosis was induced by VĪ“2 T cells. This was verified by VĪ“2 T/mesothelioma co-culture experiments demonstrating membrane ballooning morphology, increased cleaved caspase-3 and gasdermin E, and upregulated IL-1Ī² and IL-18.DiscussionVĪ“2 T cells plus anti-PD1 exhibited cytotoxicity against mesothelioma in vivo. However, we found no advantage for anti-PD-1 against PD-1 high expressing VĪ“2 T cells in promoting pyroptosis. Taken together, our work demonstrated that VĪ“2 T cells combined with anti-PD-1 antibody can be developed as a potential combination immunotherapy for mesothelioma

    HIV-1 genetic transmission networks among men who have sex with men in Kunming, China

    No full text
    <div><p>Background</p><p>Yunnan has the greatest share of reported human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) cases in China. In recent years, HIV prevalence and incidence remained stubbornly high in men who have sex with men (MSM). To follow the dynamics of the HIV-1 epidemic among MSM, HIV-1 genetic characteristics and genetic transmission networks were investigated.</p><p>Methods</p><p>Blood samples from 190 newly diagnosed HIV-1 cases among MSM were continuously collected at fixed sites from January 2013 to December 2015 in Kunming City, Yunnan Province. Partial <i>gag</i>, <i>pol</i> and <i>env</i> genes were sequenced and used for phylogenetic and genotypic drug resistance analyses. The genetic characteristics of the predominant HIV-1 strains were analyzed by the Bayesian Markov Chain Monte Carlo (MCMC) method. The genetic transmission networks were identified with a genetic distance of 0.03 substitutions/site and 90% bootstrap support.</p><p>Results</p><p>Among the 190 HIV-1 positive MSM reported during 2013ā€“2105, various genotypes were identified, including CRF01_AE (45.3%), CRF07_BC (35.8%), unique recombinant forms (URFs) (11.6%), CRF08_BC (3.2%), CRF55_01B (2.1%), subtype B (1.6%) and CRF59_01B (0.5%). The effective population sizes (EPS) for CRF01_AE and CRF07_BC increased exponentially from approximately 2001ā€“2010 and 2005ā€“2009, respectively. Genetic transmission networks were constructed with 308 <i>pol</i> sequences from MSM diagnosed during 2010ā€“2015. Of the 308 MSM, 109 (35.4%) were identified in 38 distinct clusters. Having multiple male partners was associated with a high probability of identification in the genetic transmission networks. Of the 38 clusters, 27 (71.1%) contained individuals diagnosed in different years. Of the 109 individuals in the networks, 26 (23.9%) had ā‰„2 potential transmission partners (ā‰„2 links). The proportion of MSM with ā‰„2 links was higher among those diagnosed from 2010ā€“2012. The constituent ratios of their potential transmission partners by areas showed no significant difference among MSM from Kunming, other cities in Yunnan and other provinces. Additionally, surveillance drug resistance mutations (SDRMs) were identified in 5% of individuals.</p><p>Conclusion</p><p>This study revealed the various HIV-a genotypes circulating among MSM in Kunming. MSM with more partners were more easily detected in transmission networks, and early-diagnosed MSM remained active in transmission networks. These findings suggested that the routine interventions should be combined with HIV testing and linkage to care and early antiretroviral therapy among HIV-positive MSM.</p></div

    Bayesian skyline plots of effective population sizes for the main HIV-1 strains among MSM in Yunnan.

    No full text
    <p>A, Bayesian skyline plot of effective population size for CRF01_AE; B, Bayesian skyline plot of effective population size for CRF07_BC. The black line represents the median effective population size over time. The dotted lines represent the lower and higher bounds of the 95% highest posterior density interval.</p
    corecore